Methods and compositions for regulating T cell subsets by modula

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435 6, 435 29, 435375, 435455, C12Q 102, C12Q 168, C12N 506, C12N 1509

Patent

active

059586710

ABSTRACT:
Methods for modulating production of a T helper type 2 (Th2)-associated cytokine, in particular interleukin-4, by modulating the activity of a transcription factor, in particular the proto-oncoprotein c-Maf, that regulates expression of the Th2-associated cytokine gene are disclosed. Methods for modulating development of T helper type 1 (Th1) or T helper type 2 (Th2) subsets in a subject using agents that modulate transcription factor activity are also disclosed. The methods of the invention can further involve use of agents that modulate the activity of additional transcription factors that contribute to the regulation of Th1- or Th2-associated cytokines, such as a Nuclear Factor of Activated T cells (NF-AT) protein and/or an AP-1 family protein. Compositions for modulating Th2-associated cytokine production, recombinant expression vectors and host cells, as well as screening assays to identify agents that modulate c-Maf activity, are also disclosed.

REFERENCES:
Andrews, N.C. et al., "The ubiquitous subunit of erythroid transcription factor NF-E2 is a small basic-leucine Zipper protein related to the v-maf oncogene", Proc. Natl. Acad. Sci. USA, vol. 90, pp. 11488-11492 (1993).
Casolaro, V., et al., "Inhibition of NF-AT-dependent transcription by NF -kappa B: implications for differential gene expression in T helper cell subsets", Proc Natl Acad Sci USA, vol. 92, pp. 11623-11627 (1995).
Cordes, S.P. et al., "The mouse segmentation gene kr encodes a novel basic domain-leucine zipper transcription factor", Cell, pp. 1025-1034 (1994).
Engel, J.D., "Meticulous AP-1 factors", Nature, vol. 367, pp. 516-517 (1994).
Hodge, M.R. et al., "The proximal promoter of the IL-4 gene is composed of multiple essential regulatory sites that bind at least two distinct factors", Journal of Immunology vol. 154, No. 12, pp. 6397-6405 (1995).
Hodge, M.R. et al., "Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice", Immunity vol. 4, pp. 397-405 (1996).
Fujiwara, K.T. et al., "Two new members of the maf oncogene family, mafK and mafF, encode nuclear b-Zip proteins lacking putative trans-activator domain", Oncogene, vol. 8, pp. 2371-2380 (1993).
Igarashi, K. et al., "Conditional expression of the ubiquitous transcription factor MafK induces erytholeukemia cell differentiation", Proc. Natl. Acad. Sci. USA, vol. 92, pp. 7445-7449 (1995).
Igarashi, K. et al., "Activity and expression of murine small Maf family protein MafK", J. Biol. Chem., vol. 270, pp. 7615-7624 (1995).
Itoh, K. et al., "Cloning and characterization of a novel erythroid cell-derived CNC family transcription factor heterodimerizing with the small Maf family proteins", Mol. Cell. Biol., vol. 15:8, pp. 4184-4193 (1995).
Kataoka, K. et al., "Transactiviation activity of Maf nuclear oncoprotein is modulated by Jun, Fos and small Maf proteins", Oncogene, vol. 12, pp. 53-62 (1996).
Kataoka, K. et al., "Maf nuclear oncoprotein recognizes sequences related to an AP-1 site and forms heterodimers with both Fos and Jun", Mol. Cell. Biol., vol. 14:1, pp. 700-712 (1994).
Kataoka, K. et al., "Structure-Function Analysis of the maf Oncogen Product, a Member of the b-Zip Protein Family", J. Virol., vol. 67:4, pp. 2133-2141, (1993).
Kawai, S. et al., "Isolation of the avian transforming retrovirus, AS42, carrying the v-maf oncogene and initial characterization of its gene product", Virology, vol. 88, pp. 778-784 (1992).
Liu, Q. et al., "Expression of the bZIP Transcription factor gene Nrl in the developing nervous system", Oncogene, vol. 12, pp. 207-211 (1996).
Nishizawa M. et al., "v-maf, a viral oncogene that encodes a "leucine zipper" motif", Proc. Natl. Acad. Sci. USA, vol. 86, pp. 7711-7715 (1989).
Rooney, J.W. et al., "A common factor regulates both Th1-and Th2 -specific cytokine gene expression", EMBO Journal, vol. 13(3), pp. 625-633 (1994).
Rooney, J.W. et al., "Coordinate and cooperative roles for NF -AT and AP-1 in the regulation of the murine IL--4 gene", Immunity, vol. 2, pp. 473-483 (1995).
Sieweke, M.H. et al., "MafB is an interaction partner and repressor of Ets-1 that inhibits erythroid differentiation", Cell, vol. 85, pp. 49-60 (1996).
Swaroop, A. et al. "A conserved retina-specific gene encodes a basic motif/leucine zipper domain", Proc. Natl. Acad. Sci. USA, vol. 89, pp. 266-270 (1992).
Tara, D. et al., "Characterization of the constitutive and inducible components of a T cell IL--4 activation responsive element", J Immunol, vol. 154(9), pp. 4592-602 (1995).
Wierenga, E.A. et al., Reduced NF -AT binding at the IL--4 --CLEO. element in TH2 cells of atopic patients; 9th International Congress of Immunology, Abstract 4155, Jul. 23-29 1995.
Yang-Feng, T.L. et al., "Neural retina-specific leucine zipper gene NRL (D14S46E) maps to human chromosome 14q11.1-q11.2", Genomics, vol. 14, pp. 491-492 (1992).
Kataoka et al. Small Maf proteins heterodimerize with Fos and may act as competitive repressors of the NF-E2 transcription factor. Molec. Cell. Biol. 15(4): 2180-2190, Mar. 2, 1995.
Kurschner et al. The maf proto-oncogen stimulates transcription from multiple sites in a promoter that directs Pukinje neuron-specific gene expression. Molec. Cell. Biol. 15(1): 246-254, Jan. 1995.
Peterson et al. "Transcription factor based therapeutics: drugs of the future", Trends in Biotech. 14: 11-18, Jan. 1993.
Kerppola et al. "Maf and Nrl can bind to AP-1 sites and form heterodimers with Fos and Jun", Oncogene 9: 675-684, Mar. 1994.
Igarishi et al. Regulation of transcription by dimerization of erythroid factor NF-E2 p45 with small Maf proteins. Nature 367: 568-572, Feb. 1994.
Ho et al. "The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4", Cell 85: 973-983, Jun. 1996.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Methods and compositions for regulating T cell subsets by modula does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and compositions for regulating T cell subsets by modula, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for regulating T cell subsets by modula will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-701766

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.